tezosentan has been researched along with angiotensin ii in 3 studies
| Studies (tezosentan) | Trials (tezosentan) | Recent Studies (post-2010) (tezosentan) | Studies (angiotensin ii) | Trials (angiotensin ii) | Recent Studies (post-2010) (angiotensin ii) |
|---|---|---|---|---|---|
| 157 | 29 | 33 | 38,152 | 1,089 | 7,413 |
| Protein | Taxonomy | tezosentan (IC50) | angiotensin ii (IC50) |
|---|---|---|---|
| Atrial natriuretic peptide receptor 3 | Homo sapiens (human) | 0.002 | |
| Type-1A angiotensin II receptor | Rattus norvegicus (Norway rat) | 0.002 | |
| Type-1B angiotensin II receptor | Rattus norvegicus (Norway rat) | 0.0018 | |
| Type-1 angiotensin II receptor | Homo sapiens (human) | 0.0055 | |
| Type-2 angiotensin II receptor | Rattus norvegicus (Norway rat) | 0.004 | |
| Type-2 angiotensin II receptor | Homo sapiens (human) | 0.0011 |
| Timeframe | Studies, this research(%) | All Research% |
|---|---|---|
| pre-1990 | 0 (0.00) | 18.7374 |
| 1990's | 0 (0.00) | 18.2507 |
| 2000's | 2 (66.67) | 29.6817 |
| 2010's | 1 (33.33) | 24.3611 |
| 2020's | 0 (0.00) | 2.80 |
| Authors | Studies |
|---|---|
| Boomsma, F; de Beer, VJ; Dekkers, DH; Duncker, DJ; Lamers, JM; Merkus, D; Pijnappels, DA; Sorop, O | 1 |
| Andersson, A; Fenhammar, J; Forestier, J; Frithiof, R; Hjelmqvist, H; Sollevi, A; Weitzberg, E | 1 |
| de Beer, VJ; de Graaff, HJ; Duncker, DJ; Hoekstra, M; Merkus, D | 1 |
3 other study(ies) available for tezosentan and angiotensin ii
| Article | Year |
|---|---|
Integrative control of coronary resistance vessel tone by endothelin and angiotensin II is altered in swine with a recent myocardial infarction.
Topics: Angiotensin II; Angiotensin II Type 1 Receptor Blockers; Animals; Biphenyl Compounds; Coronary Circulation; Coronary Vessels; Disease Models, Animal; Endothelin A Receptor Antagonists; Endothelin B Receptor Antagonists; Endothelins; Hemodynamics; Irbesartan; Myocardial Infarction; Oxygen; Physical Exertion; Pyridines; Receptor, Angiotensin, Type 1; Receptor, Endothelin A; Receptor, Endothelin B; Swine; Tetrazoles; Time Factors; Vascular Resistance; Vasoconstriction; Vasodilation; Ventricular Function, Left; Ventricular Remodeling | 2008 |
The endothelin receptor antagonist tezosentan improves renal microcirculation in a porcine model of endotoxemic shock.
Topics: Aldosterone; Angiotensin II; Animals; Disease Models, Animal; Endothelin Receptor Antagonists; Endotoxemia; Female; Hemodynamics; Interleukins; Kidney; Microcirculation; Osmolar Concentration; Pyridines; Random Allocation; Swine; Tetrazoles; Treatment Outcome; Tumor Necrosis Factor-alpha; Vasodilator Agents | 2008 |
Integrated control of pulmonary vascular tone by endothelin and angiotensin II in exercising swine depends on gender.
Topics: Angiotensin II; Angiotensin II Type 1 Receptor Blockers; Animals; Biphenyl Compounds; Endothelin Receptor Antagonists; Endothelins; Female; Irbesartan; Male; Models, Animal; Physical Conditioning, Animal; Pulmonary Artery; Pyridines; Receptor, Angiotensin, Type 1; Receptors, Endothelin; Sex Characteristics; Swine; Tetrazoles; Vasoconstriction; Vasodilator Agents | 2010 |